Cargando…
Tumor-Targeted Delivery of IL-2 by NKG2D Leads to Accumulation of Antigen-Specific CD8+ T Cells in the Tumor Loci and Enhanced Anti-Tumor Effects
Interleukin-2 (IL-2) has been shown to promote tumor-specific T-cell proliferation and differentiation but systemic administration of IL-2 results in significant toxicity. Therefore, a strategy that can specifically deliver IL-2 to the tumor location may alleviate concerns of toxicity. Because NKG2D...
Autores principales: | Kang, Tae Heung, Mao, Chih-Ping, He, Liangmei, Tsai, Ya-Chea, Liu, Katherine, La, Victor, Wu, T.-C., Hung, Chien-Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324421/ https://www.ncbi.nlm.nih.gov/pubmed/22509395 http://dx.doi.org/10.1371/journal.pone.0035141 |
Ejemplares similares
-
Control of spontaneous ovarian tumors by CD8+ T cells through NKG2D-targeted delivery of antigenic peptide
por: Kang, Tae Heung, et al.
Publicado: (2013) -
Creation of a Merkel cell polyomavirus small T antigen-expressing murine tumor model and a DNA vaccine targeting small T antigen
por: Gomez, Bianca, et al.
Publicado: (2013) -
In vivo microRNA-155 expression influences antigen-specific T cell-mediated immune responses generated by DNA vaccination
por: Mao, Chih-Ping, et al.
Publicado: (2011) -
Xenogeneic Human p53 DNA Vaccination by Electroporation Breaks Immune Tolerance to Control Murine Tumors Expressing Mouse p53
por: Soong, Ruey-Shyang, et al.
Publicado: (2013) -
Localization of Salmonella and albumin-IL-2 to the tumor microenvironment augments anticancer T cell immunity
por: Kung, Yu-Jui, et al.
Publicado: (2022)